Case Report: Recurrence of Testicular Myofibroblastic Tumor After Surgery

Jiayi Liu; Zhijie Bai; Shuaiqi Li; Sheng Zeng; Chuang Li; Qian Liu

doi:10.3389/fonc.2021.810708

Case Report: Recurrence of Testicular Myofibroblastic Tumor After Surgery

Front Oncol. 2022 Jan 14:11:810708. doi: 10.3389/fonc.2021.810708. eCollection 2021.

Authors

Jiayi Liu^{1

2}, Zhijie Bai², Shuaiqi Li³, Sheng Zeng², Chuang Li², Qian Liu²

Affiliations

¹ The First Central Clinical College of Tianjin Medical University, Tianjin, China.
² Department of Urology, Tianjin First Central Hospital, School of Medicine, NanKai University, Tianjin, China.
³ School of Medicine, Nankai University, Tianjin, China.

Abstract

Inflammatory myofibroblastic tumour (IMT), also known as plasma cell granuloma (PCG) or inflammatory pseudotumour (IPT), is a distinctive, rarely metastasizing neoplasm composed of myofibroblastic and fibroblastic spindle cells accompanied by inflammatory infiltration of plasma cells, lymphocytes and/or eosinophils. IMT predominantly affects children and young adults, and the age at presentation ranges from 3 to 89 years. We present a very rare case of recurrent testicular IMT without ALK rearrangement. This case highlights the clinical characteristics and diagnostic factors associated with primary and recurrent foci of this rare tumour, along with key therapeutic approaches.

Keywords: case report; inflammatory myofibroblastic tumor; inflammatory pseudotumour; plasma cell granuloma; recurrence; spindle cell neoplasms; testis.

Publication types

Case Reports